2017
DOI: 10.1007/s00415-017-8596-7 View full text |Buy / Rent full text
|
|

Abstract: Antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) have been described in patients with neuromyelitis optica spectrum disorders (NMOSD) without aquaporin-4 antibodies (AQP4-IgG). We aimed to identify the proportion of AQP4-IgG-negative NMOSD patients who are seropositive for MOG-IgG. In a cross sectional study, we reviewed all patients seen in the National NMO clinic over the last 4 years (after the availability of MOG-IgG testing), including clinical information, MRI, and antibody tests. 261 unique p… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
4
89
0

Publication Types

Select...

Relationship

0
0

Authors

Journals